A detailed history of Providence Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 148 shares of DHR stock, worth $35,648. This represents 0.01% of its overall portfolio holdings.

Number of Shares
148
Previous 148 -0.0%
Holding current value
$35,648
Previous $36,000 13.89%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$224.58 - $256.19 $12,576 - $14,346
56 Added 60.87%
148 $36,000
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $5.03 Million - $5.73 Million
-21,592 Reduced 99.58%
92 $22,000
Q2 2023

Aug 10, 2023

BUY
$224.99 - $256.14 $4.86 Million - $5.53 Million
21,600 Added 25714.29%
21,684 $5.2 Million
Q1 2023

May 17, 2023

SELL
$239.75 - $277.0 $5.06 Million - $5.84 Million
-21,087 Reduced 99.6%
84 $21,000
Q1 2023

May 17, 2023

BUY
$239.75 - $277.0 $5.02 Million - $5.8 Million
20,921 Added 8368.4%
21,171 $5.34 Million
Q1 2023

May 10, 2023

BUY
$239.75 - $277.0 $59,937 - $69,250
250 New
250 $63,000
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $2,548 - $2,950
-12 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$212.5 - $245.46 $2,550 - $2,945
12 New
12 $3,000
Q2 2020

Aug 04, 2020

SELL
$128.7 - $176.83 $7,721 - $10,609
-60 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$121.39 - $169.05 $1,820 - $2,535
-15 Reduced 20.0%
60 $8,000
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $2,002 - $2,302
15 Added 25.0%
75 $12,000
Q1 2018

May 10, 2018

SELL
$92.16 - $103.8 $10,598 - $11,937
-115 Reduced 65.71%
60 $6,000
Q4 2017

Feb 12, 2018

BUY
$85.26 - $94.62 $14,920 - $16,558
175
175 $16,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Providence Capital Advisors, LLC Portfolio

Follow Providence Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.